Yk. Jing et al., DIFFERENTIATION OF PROMYELOCYTIC LEUKEMIA-CELLS HL-60 INDUCED BY DAIDZEIN IN-VITRO AND IN-VIVO, Anticancer research, 13(4), 1993, pp. 1049-1054
We have screened more than one thousand synthetic and natural chemical
s to explore differentiation inducers and found that daidzein has pote
nt differentiation-inducing activity for human leukemia HL-60 cells, b
oth in vitro and in vivo. In vitro study showed that daidzein at conce
trations exceeding 10 mug/ml caused inhibition of HL-60 cells; and it
induced differentiation of the cells into granulacytic lineage as judg
ed by NBT reduction activity, phagocytic ability and morphological cha
racteristics. Flow cytometry study indicated that daidzein arrested HL
-60 cells in the G1 phase. The growth of HL-60 cells in the subrenal c
apsules of mice and in diffusion chambers implanted into the periotone
al cavities of mice was inhibited by 50 mg/kg daidzein. HL-60 cells tr
eated with daidzein in vivo also exhibited characteristic morphologica
l changes of matured cells. Moreover, the colony forming efficiency of
HL-60 cells in diffusion chambers in mice was markedly inhibited by t
he administration of daidzein.